WallStreetZenWallStreetZen

NASDAQ: REVB
Revelation Biosciences Inc Stock Ownership - Who owns Revelation Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Revelation Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
George F. TidmarshDirector2023-12-0827,771$0.52
$14.44kSell
George F. TidmarshDirector2023-10-1610,957$0.66
$7.24kSell
George F. TidmarshDirector2023-10-161,845$0.65
$1.20kSell
George F. TidmarshDirector2023-09-281,429$0.69
$986.01Sell
George F. TidmarshDirector2023-09-184,000$0.74
$2.96kSell
George F. TidmarshDirector2023-09-159,500$0.73
$6.94kSell
George F. TidmarshDirector2023-09-1412,000$0.75
$9.00kSell

1 of 1

REVB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REVB insiders and whales buy or sell their stock.

REVB Shareholders

What type of owners hold Revelation Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Axa Im Prime Impact Master Fund I Sca Sicavraif119.97%1,958,984$4.19MInsider
Sean H. Fitzpatrick108.37%1,769,538$3.79MInsider
Andreas Typaldos108.37%1,769,538$3.79MInsider
George F. Tidmarsh95.87%1,565,431$3.35MInsider
Lawrence Feis45.71%746,491$1.60MInsider
James Rolke41.85%683,446$1.46MInsider
Chester Stanley Zygmont Iii41.85%683,446$1.46MInsider
Walleye Capital LLC25.31%413,305$884.47kInstitution
Sabby Management LLC24.69%403,233$862.92kInstitution
Glazer Capital LLC23.34%381,106$815.57kInsider

1 of 3

REVB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REVB8.80%91.20%Net Selling
VRPX4.26%95.74%
ATXI4.45%95.55%Net Buying
CMND2.92%0.00%
FNCH1.07%98.93%Net SellingNet Selling
View Top Biotech Stocks

Revelation Biosciences Stock Ownership FAQ

Who owns Revelation Biosciences?

Revelation Biosciences (NASDAQ: REVB) is owned by 57.26% institutional shareholders, 593.17% Revelation Biosciences insiders, and 0.00% retail investors. Axa Im Prime Impact Master Fund I Sca Sicavraif is the largest individual Revelation Biosciences shareholder, owning 1.96M shares representing 119.97% of the company. Axa Im Prime Impact Master Fund I Sca Sicavraif's Revelation Biosciences shares are currently valued at $4.27M.

If you're new to stock investing, here's how to buy Revelation Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.